PSMF1 variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways.
medRxiv
2024
Development and characterization of kinase sparing TPX2-tethering Aurora kinase A ligands for cancer therapy
Cancer Res
2024
84 Suppl S
6
Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial.
BMC Cancer
2024
24
1
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry.
Geburtsh Frauenheilk
2024
84
5
459-469
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice.
Sci Signal
2024
17
834
Exploring the current state of clinical and practical teaching in obstetrics and gynecology in the era of competency-based education: a nationwide survey among German teaching coordinators.
BMC Med Educ
2024
24
1
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast
2024
74
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
BMC Cancer
2024
24
1
Managing Immune-Related Adverse Events Following Immune-Checkpoint Therapy in Patients with Gynecologic Cancer - A Survey from Germany, Austria, and Switzerland
Oncology Research and Treatment
2024
47 Suppl 1
94-94
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
NPJ Breast Cancer
2024
10
1